

A Combined Immunosuppressive Regimen for ILD MDA5-Positive Dermatomyositis

Nintedanib Slows Lung Deterioration in General Fibrosing Interstitial Lung Disease

Catch Your Breath: Insights into ILD in RA Patients

Myositis Autoantibodies as Biomarkers

MUC5B Promoter Variant Associated with RA with Interstitial Lung Disease

4 Rheumatoid Arthritis Therapy Principles, & New Drug Info

Treatment Tips for Pulmonary Arterial Hypertension & ILD

CCL2 Cytokine Serves as Biomarker in Interstitial Lung Disease
